Experts discuss non-steroidal MRAs for the treatment of patients with T2D and CKD

touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to leading experts discuss why the treatment landscape for patients with T2D and CKD requires novel therapies; why non-steroidal MRAs are being investigated in these patients and the latest clinical data; and how non-steroidal MRAs might fit into the current T2D and CKD treatment paradigm. The experts Prof. Christoph Wanner, University Hospital of Würzburg, Würzburg, Germany Dr Javed Butler, University of Mississippi Medical Center, Jackson, MS, USA  Prof. Janet McGill, Washington University School of Medicine, St. Louis, MO, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent educational grant from Bayer. This activity is jointly provided by USF Health and touchIME. For further information visit our website:  https://touchendocrinologyime.org/non-steroidal-mras-in-the-management-of-patients-with-ckd-and-t2d